Enhancement of thermoradiotherapy by glucose administration for superficial malignant tumours.
The effect of hyperglycemia on the thermoradiotherapy of superficial malignant tumours was investigated. Glucose administration alone (500 ml of 10% glucose by intravenous drip infusion) reduced the tumour blood flow, when measured by laser Doppler flowmetry, to 66.1% of the baseline level at 30 minutes after the beginning of glucose infusion. Forty patients received glucose in tandem during the hyperthermia and radiotherapy (group A), and 38 patients received thermoradiotherapy alone (group B). The mean Tave (the average temperature of all intratumoural sensors) in group A was 43.4 +/- 1.1 degrees C while that in group B was 42.5 +/- 1.2 degrees C, i.e., glucose administrations significantly increased the tumour temperature (p < 0.01). In group A, complete tumour response (CR) was observed in 12 patients (30.0%), partial response (PR) in 25 patients (62.5%) and no response (NR) in three patients (7.5%). In group B, seven (18.4%), 20 (52.7%) and 11 (28.9%) patients showed CR, PR and NR, respectively. The tumour response rates were significantly different between two treatment groups (p < 0.05). The frequency of side effects of hyperthermia in groups A and B were 22.5 and 21.1%, respectively. This study suggests that hyperglycemia enhances the effectiveness of thermoradiotherapy.
Nagata
K
K
Department of Radiology, Kansai Medical University, Osaka, Japan.
Murata
T
T
Shiga
T
T
Isoda
H
H
Aoki
Y
Y
Yamamoto
K
K
Tanaka
Y
Y
D000328:Adult; D000368:Aged; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D006979:Hyperthermia, Induced / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging / Q000628:therapy*; D011859:Radiography; D011878:Radiotherapy; D013696:Temperature
D005947:Glucose